Chemoenzymatic Labeling Pathogens Containing Terminal N-Acetylneuraminic Acid-α(2-3)-Galactose Glycans
- ACS Infect Dis. 2022 Mar 11;8(3):657-664. doi: 10.1021/acsinfecdis.2c00011.
- 1. The State Key Laboratory of Microbial Technology and National Glycoengineering Research Center, Shandong University, Qingdao 266237, China.
- 2. Medical Research Center, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining 272000, China.
- 3. Department of Gastroenterology, Qingdao Municipal Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Qingdao 266000, China.
- 4. Department of Neurology, Linyi People's Hospital, Linyi 276000, China.
- 5. Department of Clinical Laboratory, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining 272000, China.
- 6. School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.
The N-acetylneuraminic acid-α(2-3)-galactose epitope is often located at the nonreducing terminal ends of glycans on the envelopes of many pathogens, and it is believed that this structure mimics a host's oligosaccharide so as to circumvent and/or counteract the host's immune responses. A chemoenzymatic method for the rapid and sensitive detection of N-acetylneuraminic acid-α(2-3)-galactose has been built, so we planned to examine whether the chemoenzymatic method could be applied on the detection of N-acetylneuraminic acid-α(2-3)-galactose on pathogens. Our results revealed that the chemoenzymatic method was rapid and sensitive for labeling live or dead Gram-positive Streptococcus agalactiae A909 and Gram-negative Campylobacter jejuni MK104 with N-acetylneuraminic acid-α(2-3)-galactose. This study suggested that the chemoenzymatic method was a new strategy for labeling pathogens and had potential for the diagnosis of or therapeutics for pathogenic Infection.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Fluorescent DyeResearch Areas: Others